Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-08-13 17:28 (1749 d 04:22 ago) – Posting: # 20495
Views: 2,143

Hi Abhimanyu,

❝ I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.

Sounds like a bad idea.

❝ How can we find outlier? which one will be appropriate scenario for any regulatory point of view?

The trick is to avoid generating outliers. In my small universe, there is no problem that merits a solution involving identification and and removal of outliers.

Pass or fail!

Complete thread:

UA Flag
 Admin contact
23,035 posts in 4,835 threads, 1,644 registered users;
64 visitors (0 registered, 64 guests [including 8 identified bots]).
Forum time: 21:50 CEST (Europe/Vienna)

That which is static and repetitive is boring.
That which is dynamic and random is confusing.
In between lies art.    John Locke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz